How do you define personalised medicine (PerMed) and where are the biggest needs starting now?
What type of Nordic cooperation can help meet the objectives of the organisation you represent with regard to PerMed?
What would be the added Nordic value if this came true?
What initiatives do you think are needed? (e.g. political, research council)
What timeline do you foresee?
Are there any aspects of personalised medicine that the workshop did not cover or elucidate, but you consider important? Which ones?
Any additional comments
| Stensberggata 25 | NO-0170 Oslo | Norway